The dendritic cell-based cancer vaccine is an innovation in therapeutic strategy for cancer patients. Dendritic cells (DCs) are antigen presenting cells for the induction of antigen specific T cell response. DC-based immunotherapy is safe and can promote antitumor immune responses and prolonged survival of cancer patients. Wikipedia (CC BY-SA 3.0)
2023 Articles
10 196 articles
Clinical development of mRNA therapies against solid tumors
- Dawei Wu, Lingfeng Hu, Xin Wang, …, Hai-Bo Zhu, Yu Tang, Ning Li
- J Hematol Oncol, 10.1186/s13045-023-01457-x
cDC1 craves glutamine for its glory
- Stefania Vilbois, Jaeoh Park, Stefania Vilbois, …, Stefania Vilbois, Jaeoh Park, Ping-Chih Ho
- Nat Immunol, 10.1038/s41590-023-01598-8
Something old, something new: The marriage of PD-1 and IL-2
- Brendan L Horton, Stefani Spranger, Brendan L Horton, …, Stefani Spranger, Brendan L Horton, Stefani Spranger
- Immunity, 10.1016/j.immuni.2022.12.012
The advancement of metalloadjuvant for cancer immunotherapy
- Fangmin Chen, Haijun Yu, Fangmin Chen, …, Haijun Yu, Fangmin Chen, Haijun Yu
- Sci Bull (Beijing), 10.1016/j.scib.2023.03.041
Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine
- Joonsu Han, Rimsha Bhatta, Yusheng Liu, …, Yang Bo, Alberto Elosegui-Artola, Hua Wang
- Nat Commun, 10.1038/s41467-023-40886-7
Dendritic cells, headhunters for anti-tumor CD8+ T cells in triple-negative breast cancer
- Carlos Luri-Rey, Almudena Manzanal, Beatrice Pinci, …, Almudena Manzanal, Beatrice Pinci, Alvaro Teijeira
- Med, 10.1016/j.medj.2023.05.004
Stem-cell-like CD4+ T cells prey on MHC class II-negative tumors
- Joshua R Veatch, Joshua R Veatch, Joshua R Veatch, …, Stanley R Riddell, Joshua R Veatch, Stanley R Riddell
- Nat Immunol, 10.1038/s41590-023-01563-5
A Brief Overview of Cancer Vaccines
- Alexander J Muller, Sunil Thomas, George C Prendergast, …, Alexander J Muller, Sunil Thomas, George C Prendergast
- Cancer J, 10.1097/ppo.0000000000000640
Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines
- Dalil Hannani, Estelle Leplus, Karine Laulagnier, …, Karine Laulagnier, Laurence Chaperot, Joël Plumas
- None, 10.18632/genesandcancer.229
Dendritic Cell and Cancer Therapy
- Domenico Galati, Serena Zanotta, Domenico Galati, Serena Zanotta, Domenico Galati, Serena Zanotta
- Int J Mol Sci, 10.3390/ijms24044253
2022 Articles
1 112 articles
Antigen self-presenting nanovaccine for cancer immunotherapy
- Xiaoliu Liang, Hongwei Cheng, Chao Liu, …, Hongwei Cheng, Chao Liu, Gang Liu
- Sci Bull (Beijing), 10.1016/j.scib.2022.07.018
Production of dendritic cell vaccines using different methods with equivalent results: Implications for emerging centers
- Adriana da Silva Santos Duarte, Audrey Basso Zangirolami, Irene Santos, …, Simone Cristina Olenscki Gilli, Bruno Deltreggia Benites, Sara Teresinha Olalla Saad
- None, 10.1016/j.htct.2022.11.006
Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer
- Fangmin Chen, Tianliang Li, Huijuan Zhang, …, Zuoquan Xie, Min Luo, Haijun Yu
- Adv Mater, 10.1002/adma.202209910
Genetics and anatomy sculpt immune-cell partners of ovarian cancer
- Denarda Dangaj Laniti, George Coukos, Denarda Dangaj Laniti, …, George Coukos, Denarda Dangaj Laniti, George Coukos
- Nature, 10.1038/d41586-022-04169-3
Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients
- Martine Bloemendal, Kalijn F Bol, Steve Boudewijns, …, Winald R Gerritsen, Gerty Schreibelt, I Jolanda M de Vries
- Oncoimmunology, 10.1080/2162402x.2021.2015113
Dendritic Cell-Based Immunotherapies and their Potential use in Colorectal Cancer Immunotherapy
- Alia M Aldahlawi, Samaa Taha Abdullah, Alia M Aldahlawi, Samaa Taha Abdullah
- None, 10.4103/jmau.jmau_20_21
Cellular senescence enhances adaptive anticancer immunosurveillance
- Ines Marin, Manuel Serrano, Federico Pietrocola, …, Ines Marin, Manuel Serrano, Federico Pietrocola
- Oncoimmunology, 10.1080/2162402x.2022.2154115
Cell membrane-camouflaged liposomes and neopeptide-loaded liposomes with TLR agonist R848 provides a prime and boost strategy for efficient personalized cancer vaccine therapy
- Lu Shi, Hongchen Gu, Lu Shi, …, Hongchen Gu, Lu Shi, Hongchen Gu
- Nanomedicine, 10.1016/j.nano.2022.102648
Activated NK cells reprogram MDSCs via NKG2D-NKG2DL and IFN-γ to modulate antitumor T-cell response after cryo-thermal therapy
- Peng Peng, Yue Lou, Shicheng Wang, …, Jiamin Zheng, Ping Liu, Lisa X Xu
- J Immunother Cancer, 10.1136/jitc-2022-005769
Attenuated WNV-poly(A) exerts a broad-spectrum oncolytic effect by selective virus replication and CD8+ T cell-dependent immune response
- Jing Liu, Yan-Yan Hu, Qiu-Yan Zhang, …, Yuan-Qiao He, Han-Qing Ye, Bo Zhang
- Biomed Pharmacother, 10.1016/j.biopha.2022.114094